Other Information
+Added: Commercial Lease Agreement, dated June 1, 2023, between Ozone Biotech, LLC and Co-Diagnostics, Inc.
+Added: Co-Diagnostics, Inc.
+Added: Change in Control Severance Plan, (Incorporated by reference herein from Form 8-K (Exhibit 10.1) filed May 16, 2023, SEC File No.
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
12 unchanged sentences
Filed herewith.
+Added: Management Contract or Compensatory Plan or Arrangement
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
1 unchanged sentence
CO-DIAGNOSTICS,
+Added: August 10, 2023
Executive Officer, President and Principal Executive Officer
+Added: August 10, 2023
Financial Officer and Principal Financial and Accounting Officer
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.